Indasitiri nhau
-
Acadia Trofinetide Phase III Clinical Yepamusoro-Mutsara Migumisiro Yakanaka
Pana 2021-12-06, nguva yeUS, Acadia Pharmaceuticals (Nasdaq: ACAD) yakazivisa mhedzisiro yakanaka yepamusoro-yepamusoro-soro yemuyedzo wekiriniki wePhase III yemumiriri wezvinodhaka, Trofinetide.Muyedzo wechikamu chechitatu, unonzi Lavender, unonyanya kushandiswa kuongorora kuchengetedzeka uye kushanda kweTrofinetide mukurapa kweRet...Verenga zvimwe -
Kufambira mberi kwekutsvagisa kweopioid peptides kubva mukutenderwa kweDifelikefalin
Kubva muna 2021-08-24, Cara Therapeutics nemumwe wayo webhizinesi Vifor Pharma yakazivisa kuti yekutanga-mu-kirasi kappa opioid receptor agonist difelikefalin (KORSUVA™) yakabvumidzwa neFDA kurapwa kwechirwere cheitsvo chisingaperi (CKD) varwere. (yakanaka Pakati nepakati/yakaoma pruritus ine hemod...Verenga zvimwe -
RhoVac Cancer Peptide Vaccine RV001 ichave Patented neCanadian Intellectual Property Office.
Canada nguva 2022-01-24, RhoVac, kambani yemishonga yakanangana nebundu immunology, yakazivisa kuti patent yayo yekushandisa (No. 2710061) yekenza peptide vaccine RV001 ichabvumidzwa neCanadian Intellectual Property Office (CIPO).Kare, kambani yakawana patent inoenderana ...Verenga zvimwe
